Complement activation and renal dysfunction in patients with acquired thrombotic thrombocytopenic purpura

Blood. 2023 May 4;141(18):2278-2282. doi: 10.1182/blood.2022018644.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADAMTS13 Protein
  • Complement Activation
  • Humans
  • Kidney Diseases*
  • Purpura, Thrombotic Thrombocytopenic* / complications

Substances

  • ADAMTS13 Protein

Supplementary concepts

  • Thrombotic thrombocytopenic purpura, acquired